Interestingly, vtRNAs 1-1 and 2-1 can activate the NF-κB pathway, leading to a proliferative phenotype during cancer development [65, 79, 84, 85, 87, 98, 118, 128, 148–150] and triggering the inflammatory response [87, 97]. This evidence concerns the gene NFKB1 and cancer.